Skip to main content

Paula Fernandez Torres

Paula Fernandez Torres

Related news

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

El VHIR va participar activament en l'assaig clínic d'aquesta vacuna que avaluava la seguretat, la tolerabilitat i l'eficàcia.

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

Related professionals

Patricia Muñoz Cabello

Patricia Muñoz Cabello

Read more
Gloria Fatou Royo Gomes

Gloria Fatou Royo Gomes

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Albert Monserrat Companys

Albert Monserrat Companys

Read more
Mª Engracia Perez Mezquina

Mª Engracia Perez Mezquina

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.